Bone turnover markers

Defining a therapeutic target

S. A Paul Chubb, Elizabeth Byrnes, Laurens Manning, Jonathan Golledge, Peter R. Ebeling, Leon Flicker, Bu B. Yeap, Samuel D. Vasikaran

Research output: Contribution to journalLetterOtherpeer-review

5 Citations (Scopus)
Original languageEnglish
Pages (from-to)162-163
Number of pages2
JournalClinical Biochemistry
Volume50
Issue number3
DOIs
Publication statusPublished - 1 Feb 2017

Keywords

  • Fracture risk reduction
  • P1NP
  • Treatment target

Cite this

Chubb, S. A. P., Byrnes, E., Manning, L., Golledge, J., Ebeling, P. R., Flicker, L., ... Vasikaran, S. D. (2017). Bone turnover markers: Defining a therapeutic target. Clinical Biochemistry, 50(3), 162-163. https://doi.org/10.1016/j.clinbiochem.2016.09.010
Chubb, S. A Paul ; Byrnes, Elizabeth ; Manning, Laurens ; Golledge, Jonathan ; Ebeling, Peter R. ; Flicker, Leon ; Yeap, Bu B. ; Vasikaran, Samuel D. / Bone turnover markers : Defining a therapeutic target. In: Clinical Biochemistry. 2017 ; Vol. 50, No. 3. pp. 162-163.
@article{ba5e231c60a04daca5a950906111740f,
title = "Bone turnover markers: Defining a therapeutic target",
keywords = "Fracture risk reduction, P1NP, Treatment target",
author = "Chubb, {S. A Paul} and Elizabeth Byrnes and Laurens Manning and Jonathan Golledge and Ebeling, {Peter R.} and Leon Flicker and Yeap, {Bu B.} and Vasikaran, {Samuel D.}",
year = "2017",
month = "2",
day = "1",
doi = "10.1016/j.clinbiochem.2016.09.010",
language = "English",
volume = "50",
pages = "162--163",
journal = "Clinical Biochemistry",
issn = "0009-9120",
publisher = "Elsevier",
number = "3",

}

Chubb, SAP, Byrnes, E, Manning, L, Golledge, J, Ebeling, PR, Flicker, L, Yeap, BB & Vasikaran, SD 2017, 'Bone turnover markers: Defining a therapeutic target', Clinical Biochemistry, vol. 50, no. 3, pp. 162-163. https://doi.org/10.1016/j.clinbiochem.2016.09.010

Bone turnover markers : Defining a therapeutic target. / Chubb, S. A Paul; Byrnes, Elizabeth; Manning, Laurens; Golledge, Jonathan; Ebeling, Peter R.; Flicker, Leon; Yeap, Bu B.; Vasikaran, Samuel D.

In: Clinical Biochemistry, Vol. 50, No. 3, 01.02.2017, p. 162-163.

Research output: Contribution to journalLetterOtherpeer-review

TY - JOUR

T1 - Bone turnover markers

T2 - Defining a therapeutic target

AU - Chubb, S. A Paul

AU - Byrnes, Elizabeth

AU - Manning, Laurens

AU - Golledge, Jonathan

AU - Ebeling, Peter R.

AU - Flicker, Leon

AU - Yeap, Bu B.

AU - Vasikaran, Samuel D.

PY - 2017/2/1

Y1 - 2017/2/1

KW - Fracture risk reduction

KW - P1NP

KW - Treatment target

UR - http://www.scopus.com/inward/record.url?scp=84994719210&partnerID=8YFLogxK

U2 - 10.1016/j.clinbiochem.2016.09.010

DO - 10.1016/j.clinbiochem.2016.09.010

M3 - Letter

VL - 50

SP - 162

EP - 163

JO - Clinical Biochemistry

JF - Clinical Biochemistry

SN - 0009-9120

IS - 3

ER -

Chubb SAP, Byrnes E, Manning L, Golledge J, Ebeling PR, Flicker L et al. Bone turnover markers: Defining a therapeutic target. Clinical Biochemistry. 2017 Feb 1;50(3):162-163. https://doi.org/10.1016/j.clinbiochem.2016.09.010